Trial Outcomes & Findings for Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2) (NCT NCT05178173)

NCT ID: NCT05178173

Last Updated: 2024-09-19

Results Overview

Determination of qPCR of inactivity of SARS-CoV-2 cellular infectivity in COVID-19 positive patient saliva

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

230 participants

Primary outcome timeframe

Baseline, 30 minutes

Results posted on

2024-09-19

Participant Flow

Participant milestones

Participant milestones
Measure
Sterile Water
Subject participants will rinse mouth one time for 60 seconds with 20 mL of sterile water. Placebo Comparator: Sterile Water: Sterile Water Placebo Comparator
27% Ethanol Plus Essential Oils
Subject participants will rinse mouth one time for 60 seconds with 20 mL 27% ethanol plus essential oils. 27% Ethanol plus essential oils: Over-the-counter antiseptic mouth rinse
0.075% Cetylpyridinium Chloride
Subject participants will rinse mouth one time for 60 seconds with 20 mL 0.075% Cetylpyridinium Chloride. 0.075% Cetylpyridinium Chloride: Over-the-counter antiseptic mouth rinse
Overall Study
STARTED
72
77
81
Overall Study
qPCR Performed
62
67
68
Overall Study
qPCR Analysis Population
48
46
52
Overall Study
COMPLETED
72
77
79
Overall Study
NOT COMPLETED
0
0
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sterile Water
n=72 Participants
Subject participants will rinse mouth one time for 60 seconds with 20 mL of sterile water. Placebo Comparator: Sterile Water: Sterile Water Placebo Comparator
27% Ethanol Plus Essential Oils
n=77 Participants
Subject participants will rinse mouth one time for 60 seconds with 20 mL 27% ethanol plus essential oils. 27% Ethanol plus essential oils: Over-the-counter antiseptic mouth rinse
0.075% Cetylpyridinium Chloride
n=79 Participants
Subject participants will rinse mouth one time for 60 seconds with 20 mL 0.075% Cetylpyridinium Chloride. 0.075% Cetylpyridinium Chloride: Over-the-counter antiseptic mouth rinse
Total
n=228 Participants
Total of all reporting groups
Age, Categorical
<=18 years
6 Participants
n=5 Participants
2 Participants
n=7 Participants
1 Participants
n=5 Participants
9 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
66 Participants
n=5 Participants
74 Participants
n=7 Participants
78 Participants
n=5 Participants
218 Participants
n=4 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Sex: Female, Male
Female
52 Participants
n=5 Participants
54 Participants
n=7 Participants
55 Participants
n=5 Participants
161 Participants
n=4 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
23 Participants
n=7 Participants
24 Participants
n=5 Participants
67 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants
n=5 Participants
8 Participants
n=7 Participants
11 Participants
n=5 Participants
29 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
62 Participants
n=5 Participants
69 Participants
n=7 Participants
68 Participants
n=5 Participants
199 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Asian
4 Participants
n=5 Participants
7 Participants
n=7 Participants
6 Participants
n=5 Participants
17 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
14 Participants
n=5 Participants
17 Participants
n=7 Participants
13 Participants
n=5 Participants
44 Participants
n=4 Participants
Race (NIH/OMB)
White
51 Participants
n=5 Participants
51 Participants
n=7 Participants
57 Participants
n=5 Participants
159 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
6 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Region of Enrollment
United States
72 Participants
n=5 Participants
77 Participants
n=7 Participants
79 Participants
n=5 Participants
228 Participants
n=4 Participants

PRIMARY outcome

Timeframe: Baseline, 30 minutes

Population: qPCR was not performed for those participant samples with inadequate volume. qPCR was initially performed for 62 Sterile Water, 67 27% Ethanol plus essential oils, and 68 0.075% Cetylpyridinium Chloride participants; however 14, 21, and 16 samples, respectively by arm, were below the limit of detection. Thus, these samples were excluded from the final analysis.

Determination of qPCR of inactivity of SARS-CoV-2 cellular infectivity in COVID-19 positive patient saliva

Outcome measures

Outcome measures
Measure
Sterile Water
n=48 Participants
Subject participants will rinse mouth one time for 60 seconds with 20 mL of sterile water. Placebo Comparator: Sterile Water: Sterile Water Placebo Comparator
27% Ethanol Plus Essential Oils
n=46 Participants
Subject participants will rinse mouth one time for 60 seconds with 20 mL 27% ethanol plus essential oils. 27% Ethanol plus essential oils: Over-the-counter antiseptic mouth rinse
0.075% Cetylpyridinium Chloride
n=52 Participants
Subject participants will rinse mouth one time for 60 seconds with 20 mL 0.075% Cetylpyridinium Chloride. 0.075% Cetylpyridinium Chloride: Over-the-counter antiseptic mouth rinse
Change in Quantitative Polymerase Chain Reaction (qPCR) From Baseline to 30 Minutes
SARS CoV-2 N1
0.0345 natural log copies/20μL sample
Standard Deviation 2.67
-0.5577 natural log copies/20μL sample
Standard Deviation 3.55
-1.4789 natural log copies/20μL sample
Standard Deviation 4.30
Change in Quantitative Polymerase Chain Reaction (qPCR) From Baseline to 30 Minutes
SARS CoV-2 N2
0.2339 natural log copies/20μL sample
Standard Deviation 2.49
0.1822 natural log copies/20μL sample
Standard Deviation 3.05
-1.3367 natural log copies/20μL sample
Standard Deviation 3.79

Adverse Events

Sterile Water

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

27% Ethanol Plus Essential Oils

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

0.075% Cetylpyridinium Chloride

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Laura Jacox, DMD, PhD

University of North Carolina at Chapel Hill

Phone: 919-966-9731

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place